 |
|
|
|||||
Agentic AI is taking decisions and acting on behalf of users, but how to stop that going wrong?
Category:
News and Media
Bank of America downgraded Sun Pharma stock to underperform from neutral, citing risks to premium valuations and slower speciality execution. The brokerage cut its target price, flagging concerns over Ilumyas Medicare exposure, pricing pressures, and limited earnings visibility despite strong initial performance.
Category:
News and Media
UBS resumed coverage on Reliance Industries with a Buy rating and a Rs 1,750 target, citing strong prospects in Jio, retail, and new energy. The brokerage expects value unlocking across business segments, with earnings growth and sector-leading multiples supporting long-term re-rating potential for the stock.
Category:
News and Media
All news |
||||||||||||||||||
|
||||||||||||||||||